Ip et al. found that in mice, PPARα knockout resulted in significantly more severe steatohepatitis, while the administration of Wy-14643, a potent PPARα agonist, substantially prevented diet-induced NAFLD and liver injury (77). The gene discussed is PPARA; the disease is metabolic dysfunction-associated steatotic liver disease.